INTERNATIONAL OPHTHALMOLOGY, cilt.38, sa.3, ss.1021-1025, 2018 (SCI-Expanded, Scopus)
To evaluate the whether intravitreal erythropoietin (EPO) administration has any beneficial or adverse effect in patients with late-stage optic neuropathy (ON) or not.